Français
RED LIGHT INFO
This 2025 research article analyses and reviews red light therapy (Photobiomodulation) in relation to the immune system and concludes:
"This review highlights the significant potential of photobiomodulation (PBM) as an immunomodulatory tool. By influencing cellular energy production, signaling pathways, and immune cell populations, PBM offers unique approaches to managing immune-related conditions."
More details available from the link below:
Please find details of this publish article that reviews "The Mechanisms and Efficacy of Photobiomodulation Therapy for Arthritis" and concludes as follows:
"In summary, PBM therapy shows great promise as an effective and non-invasive treatment for arthritis. This review provides valuable insights and guidance for researchers interested in exploring the use of PBM therapy for arthritis treatment. With continued research and development, PBM therapy has the potential to become a widely adopted and beneficial treatment option for arthritis patients."
A range of red light wavelengths were referenced in the article from 630nm to 830nm. You can read full details via the link below.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10531845/#sec1-ijms-24-14293
We are happy to publish a link to this June 2023 study that concluded as follows:
"This clinical study confirms the interest of photobiomodulation in the treatment of the signs of skin aging. From the very first sessions, whatever the age of the person, the visible effects of reversing the signs of aging are not only observable but also measurable."
630nm was the chosen wavelength for the study. You can read full details via the link below.
Treating Psoriasis with UVB Light Therapy
UVB (ultraviolet B) light therapy is a common treatment for psoriasis, a chronic skin condition characterized by the rapid growth of skin cells, leading to red, scaly plaques. UVB light therapy involves exposing the affected skin to controlled doses of UVB light. Here's a quick overview of the process:
1. Consultation: Patients should consult a dermatologist to determine if UVB therapy is suitable for their specific type and severity of psoriasis.
2. Treatment Setup: UVB therapy is typically administered in a specialized dermatologist's office or clinic. The patient's skin is exposed to UVB light, either in a full-body chamber or through a handheld UVB device.
3. Frequency: The frequency and duration of treatment sessions vary based on the patient's condition. Initially, treatments may be brief to prevent burning, gradually increasing as the skin adapts.
4. Protection: The therapist or nurse will shield sensitive areas, such as the eyes and genitals,
UVB light treatment triggers the production of vitamin D, which is essential for healthy bones and immune system function. It also promotes the growth of new skin cells and reduces inflammation, leading to improvements in conditions such as psoriasis, eczema, and vitiligo. The treatment is usually administered in a medical setting using specialized equipment, and the dosage of UVB radiation is carefully monitored to minimize the risk of side effects such as sunburn or an increased risk of skin cancer. UVB light treatment can be used as a standalone therapy or in combination with other treatments, depending on the specific condition being treated. While the long-term effects of UVB light treatment are still being studied, current evidence suggests that it can be a safe and effective option for managing certain skin disorders.
Psoriasis
Psoriasis is an inflammatory, non-contagious skin disease that sometimes begins in childhood and adolescence, but usually in adulthood, and is usually lifelong. After allergic contact dermatitis and neurodermatitis, it is one of the most common chronic skin diseases.
The typical appearance is sharply defined, scaly reddening of the skin, which occurs primarily on the elbows, the sides of the knees and the hairy head, and is sometimes itchy. This is also indicated by the medical name of the disease, which comes from the Greek "psao" (I scratch). In addition to the skin, psoriasis also affects the joints in 5-10% of sufferers and the nails in about 50%.
Distribution
The exact number of people currently suffering from psoriasis (prevalence) can only be estimated, as sufficiently large population-based studies are not available. In principle, psoriasis can occur at any age, but studies allow us to distinguish between two types. In the early type, the so-called type 1, to which about
An Update on Narrowband Ultraviolet B Therapy for the Treatment of Skin Diseases
Abstract
The objective of this review is to provide an update on narrowband ultraviolet B (NB-UVB) as a treatment for various skin conditions. NB-UVB works by suppressing the cutaneous cell-mediated immune response and has been shown to be an efficacious and clinically tolerable treatment for a range of inflammatory dermatoses. A literature search was conducted by advanced searches of PubMed for NB-UVB treatment of dermatologic skin diseases with a focus on reports from 2010 to 2021, including both office-based and home-based phototherapy (HBPT). Data were prioritized based on studies with a high level of evidence using the Oxford Evidence-Based Medicine guidance. We found that NB-UVB continues to serve as an effective form of therapy for several cutaneous conditions, including vitiligo, psoriasis, atopic dermatitis, mycosis fungoides, and other inflammatory dermatoses. The recent introduction of Janus kinase
High-Throughput RNA Sequencing Reveals the Effect of NB-UVB Phototherapy on Major Inflammatory Molecules of Lesional Psoriasis
Conclusion: NB-UVB is an effective treatment for psoriasis. Our study supports the conclusion that the clinical effectiveness of NB-UVB therapy is based on the suppression of a broad range of inflammatory signaling pathways, gene expression of inflammatory cytokines and increased expressions of anti-inflammatory signaling pathways in psoriatic skin. This is the first study that applied advanced molecular techniques to investigate phototherapy as a new key to unlock genetic knowledge and create novel information. Ultimately, the goal is to increase medical knowledge and improve the patient care of psoriasis.
Combination of carboxytherapy with NB-UVB leads to higher percentage of repigmentation and patients' satisfaction compared to monotherapy with NB-UVB.
Carboxytherapy has been used in the treatment of autoimmune skin diseases such as psoriasis and morphea. Carboxytherapy has antioxidant effects, and leads to better tissue oxygenation, and release of growth factors. In this article, we decided to evaluate efficacy of combined carboxytherapy and narrowband-ultraviolet B (NB-UVB) compared to NB-UVB alone in the treatment of vitiligo. This is a prospective, split-body double-blind comparative study performed in patients with generalized stable vitiligo in acral areas and extremities referred to dermatology clinic of Afzalipour hospital in Kerman University of Medical Sciences. NB-UVB was performed three times a week in non-consecutive days for 4 months. In each patient, one lesion was randomly treated with carboxytherapy (weekly sessions for total of 16 sessions). Efficacy of treatment was evaluated